drugset / Trial / NCT01806363

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

NCT01806363

Phase 1 Completed 60 enrolled HanAll BioPharma Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical trial to evaluate the pharmacokinetic interactions and safety between telmisartan and chlorthalidone.

Timeline

Start
2012-11
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorthalidone Other / unclassified 25 mg Oral
Comparator Telmisartan Other / unclassified 80 mg Oral

Indications